What is Compass Pathways Plc (CMPS) stock price today?

Compass Pathways Plc (CMPS) currently trades at $9.06 per share. The stock has a market capitalization of $1.29B and a P/E ratio of —x.

Is CMPS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Compass Pathways Plc has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -3.76.

Is Compass Pathways Plc financially healthy?

Compass Pathways Plc's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -3.76 places it in the distress.

CMPS

Compass Pathways Plc

NASDAQ: CMPS · HEALTHCARE · MEDICAL CARE FACILITIES

$9.06

+8.11% today

Updated 2026-04-30

Market cap

$1.29B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.08

Dividend yield

—

52W range

$2 – $10

Volume

4.0M

Market cap

$1.29B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.08

Dividend yield

—

52W range

$2 – $10

Volume

4.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-3.8

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$21.69

+139.40%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -3.76 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-37.79M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-91.50M	$-118.46M	$-155.12M	$-287.86M	$-93.88M
EPS	—	—	—	—	$-3.08
Free cash flow	$-106.05M	$-97.44M	$-119.19M	$-157.24M	$-37.79M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-26	NATH, KABIR	Buy	367,815	—
2026-03-26	NATH, KABIR	Buy	175,000	—
2026-03-26	LOXAM, TERI	Buy	157,635	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CMPS	$1.29B	20	4.3	3.0	5.0	4.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Compass Pathways Plc trades at $9.06. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -3.76, it sits in the distress.

Frequently asked questions

What is Compass Pathways Plc's stock price?

Compass Pathways Plc (CMPS) trades at $9.06.

Is Compass Pathways Plc overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of Compass Pathways Plc (CMPS)?

The analyst target price is $21.69, representing +139.4% upside from the current price of $9.06.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-3.76 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL CARE FACILITIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

compasspathways.com

Quick metrics

P/S ratio—

ROE-565.00%

Beta2.02

50D MA$6.68

200D MA$5.92

Shares out0.13B

Float0.10B

Short ratio—

Avg volume4.0M

Performance

1 week+64.52%

1 month+74.86%

3 months+29.41%

YTD+37.10%

1 year—

3 years—

5 years—

Compare

CMPS vs LLY →CMPS vs JNJ →CMPS vs ABBV →Stock screener →